Literature DB >> 20009916

Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy.

Elizabeth Gore, Adam Currey, Nicholas Choong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20009916     DOI： 10.1097/JTO.0b013e3181c06a6f

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  15 in total

Review 1.  Accelerated dose escalation with proton beam therapy for non-small cell lung cancer.

Authors:  Daniel R Gomez; Joe Y Chang
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

Review 2.  Endoscopic management of perforations, leaks and fistulas.

Authors:  Ritu Raj Singh; Jeremy S Nussbaum; Nikhil A Kumta
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

3.  Tracheal fistula associated with bevacizumab 20 months after mediastinal radiation.

Authors:  Hideto Yamada; Wataru Shigemori; Yasushi Ryujin; Hiroshi Wada; Tetsuya Oguma; Makoto Osawa; Taishi Nagao; Yasutaka Nakano
Journal:  BMJ Case Rep       Date:  2010-11-29

4.  Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.

Authors:  Dean P Blevins; Ramona Dadu; Mimi Hu; Christina Baik; Diwakar Balachandran; William Ross; Brandon Gunn; Maria E Cabanillas
Journal:  Thyroid       Date:  2014-03-17       Impact factor: 6.568

5.  The optimal chemotherapy for stage III non-small cell lung cancer patients.

Authors:  Shirish M Gadgeel
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

6.  Combination of Palliative Thoracic Radiotherapy With Bevacizumab for Stage IV Nonsquamous NSCLC: Is There Any Impact of Time Interval on Survival?

Authors:  Weigang Xiu; Xiaotong Guo; Min Yu; Yanying Li; Yong Xu; Jiang Zhu; Jingjing Luo
Journal:  Clin Med Insights Oncol       Date:  2022-06-24

7.  Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Authors:  Daniel R Gomez; Michael Gillin; Zhongxing Liao; Caimiao Wei; Steven H Lin; Cameron Swanick; Tina Alvarado; Ritsuko Komaki; James D Cox; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-18       Impact factor: 7.038

Review 8.  Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Authors:  Ricardo Costa; Benedito A Carneiro; Sunandana Chandra; Sachin G Pai; Young Kwang Chae; Jason B Kaplan; Hannah B Garrett; Mark Agulnik; Peter A Kopp; Francis J Giles
Journal:  Drug Des Devel Ther       Date:  2016-02-29       Impact factor: 4.162

9.  Safety and efficacy of airway stenting in patients with malignant oesophago-airway fistula.

Authors:  Janusz R Włodarczyk; Jarosław Kużdżał
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

10.  Tracheal Diverticulum Following Paratracheal Hypofractionated Radiotherapy in the Setting of Prior and Subsequent Bevacizumab.

Authors:  Aadel A Chaudhuri; Jie Jane Chen; Justin N Carter; Michael S Binkley; Kiran A Kumar; Sara A Dudley; Arthur W Sung; Billy W Loo
Journal:  Cureus       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.